Determination of the Pattern of Antibiotic Resistance and Investigation of Extended-Spectrum Beta-Lactamase Production of Enterobacteriaceae Isolates of Clinical Specimens

Authors

Mojde Safari1, Hamid Abtahi2,*, Mana Shojapoor2, Majid Akbari2, Ahamadali Poorbabayi1
1Department of Microbiology, Faculty of Fundamental Sciences, Qom Azad University
2Department of Microbiology, Molecular and Medicine Research Center, Arak University of Medical Sciences
*Corresponding Author: Department of Microbiology, Molecular and Medicine Research Center, Arak University of Medical Sciences Email: [email protected]

Zahedan Journal of Research in Medical Sciences:Vol. 14, issue 8; e93266
Published online:Jan 20, 2012
Article type:Research Article
Received:Sep 27, 2011
Accepted:Oct 19, 2011
How to Cite:Safari M, Abtahi H, Shojapoor M, Akbari M, Poorbabayi A. Determination of the Pattern of Antibiotic Resistance and Investigation of Extended-Spectrum Beta-Lactamase Production of Enterobacteriaceae Isolates of Clinical Specimens. Zahedan J Res Med Sci. 2012;14(8):e93266. doi:

Abstract

Background : Extended-spectrum beta-lactamase (ESBLs) producing bacteria are issued as a serious problem considering their ability to hydrolyze most of beta-lactam antibiotics. The outbreak of infections derived by ESBL-producing enterobacteriaceae is increasing throughout the world. Therefore, this study aims to determine a pattern of antibiotic resistance and investigate the extended-spectrum beta-lactamases production of enterobacteriaceae isolates separated from clinical specimens.
Materials and Methods : In this study, 170 various strains of enterobacteriaceae isolated from clinical specimens in teaching hospitals of Arak cultured and identified applying standard methods during one year (2010-2011). The antibiotic resistance of isolates was investigated through disk Agar diffusion according to CLSI criteria. The resistant isolates against ceftazidime and cefotaxime antibiotics were studied through the combined disk test for the final confirmation of ESBL-production. The minimum inhibitory concentration was determined through micro broth dilution.
Results : In this study, the resistance rate of various strains of enterobacteriaceae against amoxiclav, cefotaxime, ceftriaxone, ceftazidime, cefoxitin, cefotetan, meropenem and imipenem were respectively, 91.1%, 70%, 68.8%, 62.9%, 28.2%, 11.1%, 11.1% and 1.7%. Among 125 resistant enterobacteriaceae isolates against ceftazidime or cefotaxime, 108 isolates (86.4%) had ESBL-positive phenotype and 17 isolates (13.6%) had ESBL-negative phenotype. The MICs of the resistant isolates were indicated within a range of 16 to 512 µg/ml for ceftazidime and 64 to 512 µg/ml for cefotaxime.
Conclusion : According to the results of this study, imipenem is the most effective antimicrobial antibiotic. On the other hand, the present study indicates that the bacteria within the family of ESBL producing enterobacteriaceae are highly prevalent among the patients. The increase in rate of such cases is often resulted by irrational antibiotic prescription. Application of new antimicrobials, limitation of the use of antimicrobial factors and increasing the utilization of infection control tools are all required in order to solve this problem.

Fulltext

The full text of this article is available on the PDF file.

References

  • 1.
    The References of this article are available on the PDF file.

Copyright

© 2012, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

30
Apr
2009

Detection of Extended-Spectrum ?-Lactamases (ESBLs) in Escherichia Coli

Freshteh Shahcheraghi,
Siavash Nasiri,
Hanieh Noveiri

Shahcheraghi F, Nasiri S, Noveiri H. Detection of Extended-Spectrum ?-Lactamases (ESBLs) in Escherichia Coli. Arch Clin Infect Dis. 2009;4(2):. doi:

26
Sep
2016

Survey of CTX-M Gene Frequency in Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae Isolates Using the Combination Disk and PCR Methods in Ahvaz, Iran

Mojtaba Moosavian,
Nazanin Ahmadkhosravy

Moosavian M, Ahmadkhosravy N. Survey of CTX-M Gene Frequency in Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae Isolates Using the Combination Disk and PCR Methods in Ahvaz, Iran. Jundishapur J Microbiol. 2016;9(11):e40423. doi: https://doi.org/10.5812/jjm.40423

1
Sep
2013

Prevalence and Antimicrobial Susceptibility Pattern of Extended Spectrum Beta Lactamase (ESBL) and non-ESBL Producing Enteric Gram-Negative Bacteria and Activity of Nitrofurantoin in the era of ESBL

Zohreh Aminzadeh,
Davood Yadegarynia,
Alireza Fatemi,
Saieed Azad Armaki,
Bahram Aslanbeygi

Aminzadeh Z, Yadegarynia D, Fatemi A, Azad Armaki S, Aslanbeygi B. Prevalence and Antimicrobial Susceptibility Pattern of Extended Spectrum Beta Lactamase (ESBL) and non-ESBL Producing Enteric Gram-Negative Bacteria and Activity of Nitrofurantoin in the era of ESBL. Jundishapur J Microbiol. 2013;6(7):e6699. doi: https://doi.org/10.5812/jjm.6699

28
May
2016

Co-occurrence of Extended-Spectrum Beta-Lactamases in Isolated Enterobacter spp. From Patients Specimens

Rashid Ramazanzadeh,
Samaneh Rouhi,
Hasan Hosainzadegan,
Pegah Shakib,
Bijan Nouri

Ramazanzadeh R, Rouhi S, Hosainzadegan H, Shakib P, Nouri B. Co-occurrence of Extended-Spectrum Beta-Lactamases in Isolated Enterobacter spp. From Patients Specimens. Arch Clin Infect Dis. 2016;11(3):e26837. doi: https://doi.org/10.5812/archcid.26837

31
Mar
2018

Prevalence and Antimicrobial Susceptibility Patterns of ESBL, AmpC and Carbapenemase-producing Enterobactericeae Isolated from Hospitalized Patients in Azerbaijan, Iran

Reza Ghotaslou,
Mohammad Reza Sadeghi,
Mohammad Taghi Akhi,
Alka Hasani,
Mohammad Asgharzadeh

Ghotaslou R, Sadeghi MR, Akhi MT, Hasani A, Asgharzadeh M. Prevalence and Antimicrobial Susceptibility Patterns of ESBL, AmpC and Carbapenemase-producing Enterobactericeae Isolated from Hospitalized Patients in Azerbaijan, Iran. Iran J Pharm Res. 2018;17(Suppl):e124751. doi: https://doi.org/10.22037/ijpr.2018.2206

More by these authors

Mojde SafariPubMedScholar
Hamid AbtahiPubMedScholar
Mana ShojapoorPubMedScholar
Majid AkbariPubMedScholar
Ahamadali PoorbabayiPubMedScholar
Share
Cited by
Metrics